3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
32
Phase EARLY_PHASE1
4
Phase 2
4
Phase 3
2
Phase 2/3
2
Phase 4
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
70
INDUSTRY
46
OTHER_GOV
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
9
Papillomavirus Infections
4
Lymphoma, Non-Hodgkin
4
Hypertension, Portal
4
Febrile Neutropenia
4
Carcinoma, Non-Small-Cell Lung
4
Polycystic Ovary Syndrome
3
Ovarian Cysts
3
Multiple Myeloma
3
Lung Neoplasms
3
Cancer Pain
3
Adenomatous Polyposis Coli
3
Recurrence
2
Rectal Neoplasms
2
Prostatic Hyperplasia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Neoplasms
2
Lymphoma, B-Cell
2
Lymphoma
2
Liver Cirrhosis
2
Leiomyoma
2
Infertility
2
Hyperthermia
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Vomiting
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Finasteride
1
Dutasteride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER_GOV
×
Prostatic Neoplasms
×
Clear all
NCT06001619
2023-08-21
PROMED
Turku University Hospital
Phase 4
Recruiting
100 enrolled